Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
Biomolecules · 02.09.2023 · 13 (9) · 1339
DOI: 10.3390/biom13091339 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 02.09.2023. Verfasst von Andrea Citarella und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Milan, Via Golgi 19, 20133 Milano, Italy. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Drug Treatment, Coronavirus 3C Proteases, Antiviral Agents. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Messina, FFABR_PA_MICALE_NICOLA_ATENEO_2022.
Abstract (Originalsprache)
The main protease (Mpro) plays a pivotal role in the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is considered a highly conserved viral target. Disruption of the catalytic activity of Mpro produces a detrimental effect on the course of the infection, making this target one of the most attractive for the treatment of COVID-19. The current success of the SARS-CoV-2 Mpro inhibitor Nirmatrelvir, the first oral drug for the treatment of severe forms of COVID-19, has further focused the attention of researchers on this important viral target, making the search for new Mpro inhibitors a thriving and exciting field for the development of antiviral drugs active against SARS-CoV-2 and related coronaviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Milan, Via Golgi 19, 20133 Milano, Italy.
- Department of Chemical and Geological Sciences, University of Cagliari, S.P. 8 CA, 09042 Cagliari, Italy.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.
ORCID-Profile: Andrea Citarella, Davide Moi, Daniele Passarella, Angela Scala, Anna Piperno, Nicola Micale
Förderung
- University of Messina
- FFABR_PA_MICALE_NICOLA_ATENEO_2022
Zitieren
APA
Citarella, A., Dimasi, A., Moi, D., Passarella, D., Scala, A., Piperno, A., & Micale, N. (2023). Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives. Biomolecules, 13(9), 1339. https://doi.org/10.3390/biom13091339
Vancouver
Citarella A, Dimasi A, Moi D, Passarella D, Scala A, Piperno A, et al. Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives. Biomolecules. 2023;13(9):1339. doi:10.3390/biom13091339
BibTeX
@article{Citarella2023,
author = {Citarella, Andrea and Dimasi, Alessandro and Moi, Davide and Passarella, Daniele and Scala, Angela and Piperno, Anna and Micale, Nicola},
title = {Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {9},
pages = {1339},
doi = {10.3390/biom13091339}
}
EUVIMED